These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 12177062
21. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively. Meijer IM, van Rotterdam W, van Zoelen EJ, van Leeuwen JE. Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581 [Abstract] [Full Text] [Related]
22. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H, Choi Y. J Biol Chem; 2001 Aug 10; 276(32):30011-7. PubMed ID: 11406619 [Abstract] [Full Text] [Related]
23. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. Peruzzi G, Molfetta R, Gasparrini F, Vian L, Morrone S, Piccoli M, Frati L, Santoni A, Paolini R. J Immunol; 2007 Aug 15; 179(4):2089-96. PubMed ID: 17675467 [Abstract] [Full Text] [Related]
24. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells. Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H, Salgia R, Lipkowitz S, Griffin JD. Oncogene; 2002 Feb 21; 21(9):1423-33. PubMed ID: 11857085 [Abstract] [Full Text] [Related]
25. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination. Bezsonova I, Bruce MC, Wiesner S, Lin H, Rotin D, Forman-Kay JD. Biochemistry; 2008 Aug 26; 47(34):8937-49. PubMed ID: 18680311 [Abstract] [Full Text] [Related]
26. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML, Miyake S, Meissner-Lula N, Hsu VW, Band H. J Biol Chem; 2000 Jan 07; 275(1):367-77. PubMed ID: 10617627 [Abstract] [Full Text] [Related]
27. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. Kaabeche K, Lemonnier J, Le Mée S, Caverzasio J, Marie PJ. J Biol Chem; 2004 Aug 27; 279(35):36259-67. PubMed ID: 15190072 [Abstract] [Full Text] [Related]
28. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling. Rorsman C, Tsioumpekou M, Heldin CH, Lennartsson J. J Biol Chem; 2016 May 27; 291(22):11608-18. PubMed ID: 27048651 [Abstract] [Full Text] [Related]
30. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation. Masson K, Heiss E, Band H, Rönnstrand L. Biochem J; 2006 Oct 01; 399(1):59-67. PubMed ID: 16780420 [Abstract] [Full Text] [Related]
33. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Zeng S, Xu Z, Lipkowitz S, Longley JB. Blood; 2005 Jan 01; 105(1):226-32. PubMed ID: 15315962 [Abstract] [Full Text] [Related]
34. Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin A1 by Rho-kinase. Kaneko T, Maeda A, Takefuji M, Aoyama H, Nakayama M, Kawabata S, Kawano Y, Iwamatsu A, Amano M, Kaibuchi K. Genes Cells; 2005 Oct 01; 10(10):973-87. PubMed ID: 16164598 [Abstract] [Full Text] [Related]
40. Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. Mosesson Y, Shtiegman K, Katz M, Zwang Y, Vereb G, Szollosi J, Yarden Y. J Biol Chem; 2003 Jun 13; 278(24):21323-6. PubMed ID: 12719435 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]